Stress Induced by the COVID-19 Pandemic & Nonconfinement: Study of Anxiety

Status Terminated

Clinical Trial Summary

The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).

Clinical Trial Description

The COVID-19 pandemic and prevention strategise have strongly impacted family lives, social lives, professional lives, and income; resulting in increased reporting of stress and anxiety within patients. This risk of infection 'post-confinement' is an additional source of stress for people returning to their professional and social lives. There are evidence showing a relationship between stress, immunity and the prognosis of several infections and inflammatory diseases. The COVID-19 pandemic and prevention strategise have strongly impacted family lives and induced a high level of anxiety and other types of stress. This risk of infection 'post-confinement' is an additional source of stress for people returning to their professional and social life. There are evidences showing a relationship between stress, immunity and the prognosis of several infections and inflammatory diseases. The aim of this project is to launch an online survey that measures population stress felt during the pandemic and post-confinement time and possible effects on eventual immune mediated disorders (allergies, auto-immunity..) through the report of new events or flares. The stress will first be measured on standardized anxiety GAD-7scale but also on more parameters (ISQ, PHQ-9, PTSD-8, and ECR-S). Socio-economic and environmental parameters will be recorded. Level of anxiety and other stress parameters as well as occurrence of inflammatory events will be measured according to the calendar and confinement /post confinement timing. Risk factors will be looked for, by multi parametric data analysis. The survey has been built in a user-friendly, accessible way so the investigators can expect a high number of participants (at least 400), especially as people are highly concerned by the situation and will be motivated to take part. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04491071
Study type	Observational
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact
Status	Terminated
Phase
Start date	October 22, 2020
Completion date	September 29, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05322161` - Yoga in the NICU for Parents Study	N/A
Completed	`NCT02680730` - The Listening Project at the ADD Centre and Biofeedback Institute of Toronto	N/A
Completed	`NCT03311529` - Effectiveness and Underlying Mechanisms of Applied Relaxation as Indicated Preventive Intervention	N/A
Completed	`NCT03056872` - Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes
Withdrawn	`NCT03271086` - Relaxation Breathing Training for Children	N/A
Completed	`NCT02398422` - The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services	N/A
Completed	`NCT02064257` - The Listening Project: Tuning Into Change	N/A
Recruiting	`NCT05784259` - Development of Transdiagnostic Single-session Treatment	N/A
Completed	`NCT03934658` - Remote Study of NightWare for PTSD With Nightmares	N/A
Recruiting	`NCT05712057` - Neurostimulation Versus Therapy for Problems With Emotions	N/A
Completed	`NCT05573009` - The Effect of Stress Reduction Program on Pregnancy Process and Mental Health in High Risk Pregnant Women	N/A
Withdrawn	`NCT03258476` - Guanfacine Extended Release and Mindfulness Skills Therapy	Phase 4
Enrolling by invitation	`NCT04396600` - The Professional Peer Resilience Initiative
Completed	`NCT03550833` - Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Multifactorial and Integrative Psychological Model
Recruiting	`NCT05415163` - Vascular Photobiomodulation on Sleep Qualityand Stress	N/A
Not yet recruiting	`NCT06235177` - Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues	Early Phase 1
Completed	`NCT04584021` - Use of Wearable Devices to Assess the Impact of Stress in Workers' Life Quality
Completed	`NCT04083300` - Cancer, Physical Activity and Quality of Life- a Longterm Follow up
Terminated	`NCT05260541` - A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder	Phase 2
Active, not recruiting	`NCT06234371` - Financial Incentives for Veteran Therapy Completion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity. — SCEI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms